Abstract
The psychostimulant methylphenidate was used to treat 30 depressed cancer patients in whom rapid response and minimization of the usual side effects of tricyclic antidepressants were desirable. Ten showed marked improvement and 13 moderate improvement, achieved within days and with few side effects. Eleven of these patients were treated for a year without evidence of tolerance or abuse.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the Academy of Consultation-Liaison Psychiatry
Paper Title
Journal
Date
